Method For Determining the Total Clotting Activity of a Blood or Plasma Sample
AssigneeHaemoSys GmbH
InventorsGotz Nowak, Elke Bucha, Ute Lange
Life of this patent
Estimating the term…
Abstract
The invention relates to a method for determining the total clotting activity of a blood or plasma sample, characterized in that a highly specific, not irreversible thrombin inhibitor is added to a blood or plasma sample in a defined amount, the clotting of the blood or plasma sample is induced and, after a defined period of time, the consumed amount of the added thrombin inhibitor is determined in a per se known manner, as well as to a kit for obtaining information about the state of coagulation of a blood sample.
Claims9
1-8. (canceled)
A method for determining the total clotting activity of a blood or plasma sample, the method comprising:
- adding a highly specific, not irreversible thrombin inhibitor to a blood or plasma sample in a defined amount, the clotting of the blood or plasma sample is induced;
- and
- determining the consumed amount of the added thrombin inhibitor.
A kit for determining the total clotting activity of a blood sample, the kit comprising:
- i) a highly specific, not irreversible thrombin inhibitor,
- ii) factors for the extrinsic and intrinsic activation of the thrombin
- iii) reagents and adjuvants, comprising reagents and adjuvants for determining the thrombin inhibitor.
Dependencies are inferred from the claim text.